{
    "nctId": "NCT05496101",
    "briefTitle": "CLI and FAR for Intraoperative Margin Assessment",
    "officialTitle": "Intraoperative Assessment of Tumour Excision Margins Using the LightPath Imaging System for Cerenkov Luminescence Imaging (CLI) Combined With Flexible Autoradiography (FAR) in Women Undergoing Breast-conserving Surgery (BCS)",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Margin status of WLE specimens",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u2022 Female subjects \u226518 years of age with a diagnosis of invasive breast cancer scheduled to undergo BCS\n\n  * Subjects who are able to give voluntary, written informed consent to participate in this study\n  * Subjects who are able to understand this study and are willing to complete all the study assessments\n  * Female subjects of childbearing age must have a negative pregnancy test (by Beta human chorionic gonadotrophin (\u03b2-HCG) qualitative analysis) or must have had a history of a surgical sterilisation or must give history of no menses in the past twelve months.\n\nExclusion Criteria:\n\n* Subjects who have had surgery to the ipsilateral breast in the past 12 months\n* Subjects who have had radiotherapy to the ipsilateral breast\n* Subjects who have a known hypersensitivity to 18F-FDG\n* Subjects who are pregnant or lactating\n* Subjects who have an existing medical condition that would compromise their participation in the study",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}